BELOTTI DANIELA

Pubblicazioni

  • Magnani, C., Gaipa, G., Lussana, F., Belotti, D., Gritti, G., Napolitano, S., et al. (2020). Sleeping Beauty-engineered CAR T cells achieve anti-leukemic activity without severe toxicities. THE JOURNAL OF CLINICAL INVESTIGATION. Dettaglio
  • Introna, M., Lussana, F., Algarotti, A., Gotti, E., Valgardsdottir, R., Micò, C., et al. (2017). Phase II Study of Sequential Infusion of Donor Lymphocyte Infusion and Cytokine-Induced Killer Cells for Patients Relapsed after Allogeneic Hematopoietic Stem Cell Transplantation. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 23(12), 2070-2078. Dettaglio
  • BELOTTI, D., GAIPA, G., Bassetti, B., Cabiati, B., Spaltro, G., BIAGI, E., et al. (2015). Full GMP-Compliant Validation of Bone Marrow-Derived Human CD133+ Cells as Advanced Therapy Medicinal Product for Refractory Ischemic Cardiomyopathy. BIOMED RESEARCH INTERNATIONAL, 2015. Dettaglio
  • Introna, M., Lucchini, G., Dander, E., Galimberti, S., Rovelli, A., Balduzzi, A., et al. (2014). Treatment of Graft versus Host Disease with Mesenchymal Stromal Cells: A Phase I Study on 40 Adult and Pediatric Patients. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 20(3), 375-381. Dettaglio
  • Dander, E., Lucchini, G., Vinci, P., Introna, M., Masciocchi, F., Perseghin, P., et al. (2012). Mesenchymal stromal cells for the treatment of graft-versus-host disease: understanding the in vivo biological effect through patient immune monitoring. LEUKEMIA. Dettaglio